175 related articles for article (PubMed ID: 12113024)
21. Preclinical and clinical trials of topoisomerase inhibitors.
Saijo N
Ann N Y Acad Sci; 2000; 922():92-9. PubMed ID: 11193928
[TBL] [Abstract][Full Text] [Related]
22. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer.
Noda K; Nishiwaki Y; Kawahara M; Negoro S; Sugiura T; Yokoyama A; Fukuoka M; Mori K; Watanabe K; Tamura T; Yamamoto S; Saijo N;
N Engl J Med; 2002 Jan; 346(2):85-91. PubMed ID: 11784874
[TBL] [Abstract][Full Text] [Related]
23. Current status of irinotecan in lung cancer.
Fukuoka M
Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):6-7. PubMed ID: 11221022
[TBL] [Abstract][Full Text] [Related]
24. Randomized phase III trial of cisplatin/irinotecan versus cisplatin/etoposide in patients with extensive-stage small-cell lung cancer.
Lara PN; Gandara DR; Natale RB
Clin Lung Cancer; 2006 Mar; 7(5):353-6. PubMed ID: 16640809
[No Abstract] [Full Text] [Related]
25. Evolving role of irinotecan in small-cell lung cancer.
Spigel DR; Greco FA
Clin Adv Hematol Oncol; 2003 Aug; 1(8):482-5. PubMed ID: 16258436
[TBL] [Abstract][Full Text] [Related]
26. Irinotecan, cisplatin/carboplatin, and COX-2 inhibition in small-cell lung cancer.
Natale RB
Oncology (Williston Park); 2003 Jul; 17(7 Suppl 7):22-6. PubMed ID: 12886870
[TBL] [Abstract][Full Text] [Related]
27. A combination chemotherapy of carboplatin and irinotecan with granulocyte colony-stimulating factor (G-CSF) support in elderly patients with small cell lung cancer.
Okamoto H; Naoki K; Narita Y; Hida N; Kunikane H; Watanabe K
Lung Cancer; 2006 Aug; 53(2):197-203. PubMed ID: 16781005
[TBL] [Abstract][Full Text] [Related]
28. Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancer.
Johnson FM; Kurie JM; Peeples BO; Lee JJ; Feng L; Pisters KM; Fossella FV; Papadimitrakopoulou VA; Blumenschein GR; Komaki R; Glisson BS
Clin Lung Cancer; 2003 Jul; 5(1):40-5. PubMed ID: 14596703
[TBL] [Abstract][Full Text] [Related]
29. Camptothecin and taxane regimens for small-cell lung cancer.
Kwong MS; Bleickardt E; Murren JR
Oncology (Williston Park); 2002 Sep; 16(9 Suppl 9):33-8. PubMed ID: 12375799
[TBL] [Abstract][Full Text] [Related]
30. [Chemotherapy for small-cell lung cancer].
Ueoka H; Kiura K; Tabata M; Bessho A; Matsushita A; Chikamori K; Yamane H; Harada M; Kimura I; Ohnoshi T
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():87-91. PubMed ID: 9216192
[TBL] [Abstract][Full Text] [Related]
31. Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer.
Briasoulis E; Samantas E; Kalofonos H; Skarlos D; Makatsoris T; Christodoulou C; Fountzilas G; Bamias A; Dimopoulos MA; Kosmidis P; Pavlidis N
Cancer Chemother Pharmacol; 2005 Nov; 56(5):521-8. PubMed ID: 15959778
[TBL] [Abstract][Full Text] [Related]
32. [Irinotecan-containing combinations in solid tumors, except colonic carcinomas].
Couteau C; Armand JP
Bull Cancer; 1998 Dec; Spec No():47-50. PubMed ID: 9932085
[TBL] [Abstract][Full Text] [Related]
33. [Chemotherapy for lung cancer patients].
Uramoto H; Kagami S; Iwashige A; Tsukada J
J UOEH; 2006 Mar; 28(1):75-84. PubMed ID: 16541742
[TBL] [Abstract][Full Text] [Related]
34. Phase II study of etoposide and cisplatin with concurrent twice-daily thoracic radiotherapy followed by irinotecan and cisplatin in patients with limited-disease small-cell lung cancer: West Japan Thoracic Oncology Group 9902.
Saito H; Takada Y; Ichinose Y; Eguchi K; Kudoh S; Matsui K; Nakagawa K; Takada M; Negoro S; Tamura K; Ando M; Tada T; Fukuoka M;
J Clin Oncol; 2006 Nov; 24(33):5247-52. PubMed ID: 17114657
[TBL] [Abstract][Full Text] [Related]
35. [Chemotherapy for non-small cell lung cancer].
Shinkai T; Saijo N
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():92-8. PubMed ID: 9216193
[TBL] [Abstract][Full Text] [Related]
36. [Randomized controlled trials in Japan--lung cancer].
Ichinose Y
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1516-21. PubMed ID: 12355937
[TBL] [Abstract][Full Text] [Related]
37. Phase II study of a 3-week schedule of irinotecan combined with cisplatin in previously untreated extensive-stage small-cell lung cancer.
Lee JE; Park HS; Jung SS; Kim JO; Kim SY
Oncology; 2007; 73(1-2):76-80. PubMed ID: 18334853
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy of small cell lung cancer: state of the art.
Chrystal K; Cheong K; Harper P
Curr Opin Oncol; 2004 Mar; 16(2):136-40. PubMed ID: 15075905
[TBL] [Abstract][Full Text] [Related]
39. Pilot study of concurrent etoposide and cisplatin plus accelerated hyperfractionated thoracic radiotherapy followed by irinotecan and cisplatin for limited-stage small cell lung cancer: Japan Clinical Oncology Group 9903.
Kubota K; Nishiwaki Y; Sugiura T; Noda K; Mori K; Kawahara M; Negoro S; Watanabe K; Imamura F; Tamura T; Saijo N
Clin Cancer Res; 2005 Aug; 11(15):5534-8. PubMed ID: 16061870
[TBL] [Abstract][Full Text] [Related]
40. Fractionated administration of irinotecan and cisplatin in Japanese patients with extensive-stage-disease small-cell lung cancer.
Takigawa N; Kiura K; Tabata M; Tanimoto M
J Clin Oncol; 2006 Nov; 24(32):5175; author reply 5175-6. PubMed ID: 17093285
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
